Desloratadine: A Viewpoint by James H. Day and Elizabeth Rafeiro

ISSN： 0012-6667

Source： Drugs, Vol.61, Iss.6, 2001-01, pp. : 797-797

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Colesevelam: A Viewpoint by James Shepherd

By Shepherd J.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 2, 2001-01 ,pp. : 147-148

Adis International

Access to resources Recommend Favorite

Desloratadine

By McClellan K. Jarvis B.

Drugs, Vol. 61, Iss. 6, 2001-01 ,pp. : 789-796

Adis International

Access to resources Recommend Favorite

Zaleplon: A Viewpoint by James K. Walsh

By Walsh J.K.

CNS Drugs, Vol. 11, Iss. 5, 1999-05 ,pp. : 393-394

Adis International

Access to resources Recommend Favorite

Rasagiline: A Viewpoint by Wolfgang H. Oertel

By Oertel Wolfgang H.

Drugs & Aging, Vol. 22, Iss. 1, 2005-01 ,pp. : 93-94

Adis International

Access to resources Recommend Favorite

Telmisartan: A Viewpoint by H.L. Elliott

By Elliott H.L.

Drugs, Vol. 56, Iss. 6, 1998-12 ,pp. : 1045-1046

Adis International

Access to resources Recommend Favorite